ID   SMS2_RAT                Reviewed;         365 AA.
AC   Q4JM44; Q5U2Z1;
DT   12-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2006, sequence version 2.
DT   24-JUL-2024, entry version 99.
DE   RecName: Full=Phosphatidylcholine:ceramide cholinephosphotransferase 2;
DE            EC=2.7.8.27 {ECO:0000250|UniProtKB:Q8NHU3};
DE   AltName: Full=Sphingomyelin synthase 2;
GN   Name=Sgms2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RX   PubMed=17210739; DOI=10.1677/joe-06-0002;
RA   Lee N.P.Y., Mruk D.D., Xia W., Cheng C.Y.;
RT   "Cellular localization of sphingomyelin synthase 2 in the seminiferous
RT   epithelium of adult rat testes.";
RL   J. Endocrinol. 192:17-32(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Brown Norway; TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=21980337; DOI=10.1371/journal.pone.0023644;
RA   Subathra M., Qureshi A., Luberto C.;
RT   "Sphingomyelin synthases regulate protein trafficking and secretion.";
RL   PLoS ONE 6:e23644-e23644(2011).
CC   -!- FUNCTION: Sphingomyelin synthase that primarily contributes to
CC       sphingomyelin synthesis and homeostasis at the plasma membrane.
CC       Catalyzes the reversible transfer of phosphocholine moiety in
CC       sphingomyelin biosynthesis: in the forward reaction transfers
CC       phosphocholine head group of phosphatidylcholine (PC) on to ceramide
CC       (CER) to form ceramide phosphocholine (sphingomyelin, SM) and
CC       diacylglycerol (DAG) as by-product, and in the reverse reaction
CC       transfers phosphocholine from SM to DAG to form PC and CER. The
CC       direction of the reaction appears to depend on the levels of CER and
CC       DAG in the plasma membrane (By similarity). Does not use free
CC       phosphorylcholine or CDP-choline as donors (By similarity). Can also
CC       transfer phosphoethanolamine head group of phosphatidylethanolamine
CC       (PE) on to ceramide (CER) to form ceramide phosphoethanolamine (CPE)
CC       (By similarity). Regulates receptor-mediated signal transduction via
CC       mitogenic DAG and proapoptotic CER, as well as via SM, a structural
CC       component of membrane rafts that serve as platforms for signal
CC       transduction and protein sorting (By similarity). To a lesser extent,
CC       plays a role in secretory transport via regulation of DAG pool at the
CC       Golgi apparatus and its downstream effects on PRKD1 (PubMed:21980337).
CC       Required for normal bone matrix mineralization (By similarity).
CC       {ECO:0000250|UniProtKB:Q8NHU3, ECO:0000269|PubMed:21980337}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + an N-acylsphing-4-
CC         enine = a 1,2-diacyl-sn-glycerol + a sphingomyelin;
CC         Xref=Rhea:RHEA:18765, ChEBI:CHEBI:17636, ChEBI:CHEBI:17815,
CC         ChEBI:CHEBI:52639, ChEBI:CHEBI:57643; EC=2.7.8.27;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18766;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18767;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + an N-
CC         acylsphing-4-enine = 1,2-dihexadecanoyl-sn-glycerol + a
CC         sphingomyelin; Xref=Rhea:RHEA:43324, ChEBI:CHEBI:17636,
CC         ChEBI:CHEBI:52639, ChEBI:CHEBI:72999, ChEBI:CHEBI:82929;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43325;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:43326;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-acyl-sn-3-glycerol + a sphingomyelin = a
CC         1-(9Z-octadecenoyl)-2-acyl-sn-glycero-3-phosphocholine + an N-
CC         acylsphing-4-enine; Xref=Rhea:RHEA:43320, ChEBI:CHEBI:17636,
CC         ChEBI:CHEBI:52639, ChEBI:CHEBI:78421, ChEBI:CHEBI:82983;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43321;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:43322;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + N-
CC         hexadecanoylsphinganine = a 1,2-diacyl-sn-glycerol + N-hexadecanoyl-
CC         sphinganine-1-phosphocholine; Xref=Rhea:RHEA:41796,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:57643, ChEBI:CHEBI:67042,
CC         ChEBI:CHEBI:78647; Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41797;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:41798;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + N-hexadecanoyl-
CC         (4R)-hydroxysphinganine = a 1,2-diacyl-sn-glycerol + N-hexadecanoyl-
CC         (4R)-hydroxysphinganine-phosphocholine; Xref=Rhea:RHEA:42140,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:57643, ChEBI:CHEBI:65107,
CC         ChEBI:CHEBI:78650; Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42141;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:42142;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + N-
CC         hexadecanoylsphinganine = a 1,2-diacyl-sn-glycerol + N-hexadecanoyl-
CC         sphinganine-1-phosphoethanolamine; Xref=Rhea:RHEA:42128,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:64612, ChEBI:CHEBI:67042,
CC         ChEBI:CHEBI:78654; Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42129;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + N-
CC         hexadecanoyl-(4R)-hydroxysphinganine = a 1,2-diacyl-sn-glycerol + N-
CC         hexadecanoyl-(4R)-hydroxysphinganine-1-phosphoethanolamine;
CC         Xref=Rhea:RHEA:42144, ChEBI:CHEBI:17815, ChEBI:CHEBI:64612,
CC         ChEBI:CHEBI:65107, ChEBI:CHEBI:78656;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42145;
CC         Evidence={ECO:0000250|UniProtKB:Q8NHU3};
CC   -!- PATHWAY: Sphingolipid metabolism. {ECO:0000250|UniProtKB:Q8NHU3}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8NHU3};
CC       Multi-pass membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q8NHU3}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Primarily localized at the plasma membrane with a
CC       small fraction at the Golgi apparatus. {ECO:0000250|UniProtKB:Q8NHU3}.
CC   -!- TISSUE SPECIFICITY: Expression restricted to late round spermatids and
CC       elongating spermatids but not detected in late elongate spermatids and
CC       Sertoli cells (at protein level). {ECO:0000269|PubMed:17210739}.
CC   -!- PTM: Palmitoylated on Cys-331, Cys-332, Cys-343 and Cys-348; which
CC       plays an important role in plasma membrane localization. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the sphingomyelin synthase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ071571; AAY84706.2; -; mRNA.
DR   EMBL; BC085803; AAH85803.1; -; mRNA.
DR   RefSeq; NP_001014065.1; NM_001014043.1.
DR   RefSeq; XP_006233373.1; XM_006233311.3.
DR   RefSeq; XP_008759723.1; XM_008761501.1.
DR   RefSeq; XP_017446423.1; XM_017590934.1.
DR   AlphaFoldDB; Q4JM44; -.
DR   SMR; Q4JM44; -.
DR   STRING; 10116.ENSRNOP00000015020; -.
DR   PhosphoSitePlus; Q4JM44; -.
DR   PaxDb; 10116-ENSRNOP00000015020; -.
DR   GeneID; 310849; -.
DR   KEGG; rno:310849; -.
DR   AGR; RGD:1305778; -.
DR   CTD; 166929; -.
DR   RGD; 1305778; Sgms2.
DR   eggNOG; KOG3058; Eukaryota.
DR   InParanoid; Q4JM44; -.
DR   OrthoDB; 1343173at2759; -.
DR   PhylomeDB; Q4JM44; -.
DR   TreeFam; TF314547; -.
DR   BRENDA; 2.7.8.27; 5301.
DR   Reactome; R-RNO-1660661; Sphingolipid de novo biosynthesis.
DR   PRO; PR:Q4JM44; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0047493; F:ceramide cholinephosphotransferase activity; ISO:RGD.
DR   GO; GO:0002950; F:ceramide phosphoethanolamine synthase activity; ISO:RGD.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0033188; F:sphingomyelin synthase activity; ISO:RGD.
DR   GO; GO:0046513; P:ceramide biosynthetic process; ISO:RGD.
DR   GO; GO:1905373; P:ceramide phosphoethanolamine biosynthetic process; ISO:RGD.
DR   GO; GO:0030500; P:regulation of bone mineralization; ISS:UniProtKB.
DR   GO; GO:0006686; P:sphingomyelin biosynthetic process; ISO:RGD.
DR   CDD; cd01610; PAP2_like; 1.
DR   InterPro; IPR045221; Sphingomyelin_synth-like.
DR   InterPro; IPR025749; Sphingomyelin_synth-like_dom.
DR   PANTHER; PTHR21290:SF24; PHOSPHATIDYLCHOLINE:CERAMIDE CHOLINEPHOSPHOTRANSFERASE 2; 1.
DR   PANTHER; PTHR21290; SPHINGOMYELIN SYNTHETASE; 1.
DR   Pfam; PF14360; PAP2_C; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Golgi apparatus; Kinase; Lipid metabolism; Lipoprotein;
KW   Membrane; Palmitate; Reference proteome; Sphingolipid metabolism;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..365
FT                   /note="Phosphatidylcholine:ceramide
FT                   cholinephosphotransferase 2"
FT                   /id="PRO_0000290123"
FT   TRANSMEM        80..100
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        128..148
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        159..179
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        219..239
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        248..268
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        273..290
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        291..365
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          9..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..28
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        229
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        272
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        276
FT                   /evidence="ECO:0000250"
FT   LIPID           331
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           332
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           343
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           348
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        264
FT                   /note="I -> V (in Ref. 2; AAH85803)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   365 AA;  42223 MW;  A3BD73AFF11245D0 CRC64;
     MDIIETAKLE GHLESQTNNS TNTYTSPTEA VEEEDKNGKG KPKTLSNGLR KGAKKYPDYI
     QISMPNDSRN KLPLEWWKTG IAFVYALFNL ILTTVMITVV HERVPPKELS PPLPDKFFDY
     VDRVKWAFSV SEINGMVLVG LWLTQWLFLR YKSIVGRRFF FIMGTLYLYR CITMYVTTLP
     VPGMHFQCAP KLNGDSQAKI QRILRLLSGG GLSITGSHIL CGDFLFSGHT VVLTLTYLFI
     KEYSPRHFWW YHLVCWLLSA AGIICILVAH EHYTVDVIIA YYITTRLFWW YHSMANEKNL
     KVSSQTNFLS RAWWFPIFYF FEKNVQGSIP CCFSWPLSWP PGCFKSSCKK YSRVQKIGED
     NEKST
//
